AI assistant
Sending…
Ernexa Therapeutics Inc. — Director's Dealing 2012
Jun 11, 2012
35259_dirs_2012-06-11_bbf91cf4-adde-4c91-8626-d6183473a440.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NTN BUZZTIME INC (NTN)
CIK: 0000748592
Period of Report: 2012-06-08
Reporting Person: Bateman Terry Allan (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-06-08 | Stock Options (Right to Buy) | $0.14 | A | 20000 | Acquired | 2022-06-08 | Common Stock (20000) | Direct |
Footnotes
F1: Stock option granted under the NTN Buzztime, Inc. 2010 Performance Incentive Plan. The options vest and become exercisable in 12 equal monthly installments from the date of gra
More from Ernexa Therapeutics Inc.
Major Shareholding Notification
2026
May 14
Annual Report
2026
May 11
Proxy Solicitation & Information Statement
2026
May 11
Proxy Solicitation & Information Statement
2026
May 11
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 24